» Authors » Gemma Caballero

Gemma Caballero

Explore the profile of Gemma Caballero including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 250
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gianella S, Anderson C, Chaillon A, Wells A, Porrachia M, Caballero G, et al.
AIDS . 2024 Mar; 38(8):1131-1140. PMID: 38526550
Objective: We sought to determine if standard influenza and pneumococcal vaccines can be used to stimulate HIV reservoirs during antiretroviral therapy (ART). Design: A prospective, randomized, double-blinded, placebo-controlled, crossover trial...
2.
Goyal R, de Gruttola V, Gianella S, Caballero G, Porrachia M, Ignacio C, et al.
PLoS One . 2023 Sep; 18(9):e0291367. PMID: 37751407
Objective: Identify system-level features in HIV migration within a host across body tissues. Evaluate heterogeneity in the presence and magnitude of these features across hosts. Method: Using HIV DNA deep...
3.
Gianella S, Rawlings S, Dobrowolski C, Nakazawa M, Chaillon A, Strain M, et al.
Clin Infect Dis . 2021 Oct; 75(1):73-80. PMID: 34612493
Background: Sex differences in human immunodeficiency virus (HIV) reservoir dynamics remain underexplored. Methods: Longitudinal samples from virally suppressed midlife women (n = 59, median age 45 years) and age-matched men...
4.
Chaillon A, Nakazawa M, Rawlings S, Curtin G, Caballero G, Scott B, et al.
J Virol . 2020 Jul; 94(19). PMID: 32641485
Cytomegalovirus (CMV) almost universally infects persons with HIV (PWH), and it is a driver of persistent inflammation and HIV persistence. The mechanisms underlying the association between CMV (and possibly other...
5.
Gianella S, Chaillon A, Chun T, Sneller M, Ignacio C, Vargas-Meneses M, et al.
J Virol . 2020 May; 94(15). PMID: 32434884
If strategies currently in development succeed in eradicating HIV reservoirs in peripheral blood and lymphoid tissues, residual sources of virus may remain in anatomic compartments. Paired blood and semen samples...
6.
Gianella S, Moser C, Vitomirov A, McKhann A, Layman L, Scott B, et al.
AIDS . 2020 Apr; 34(6):849-857. PMID: 32271250
Background: Even with antiretroviral therapy (ART), persons with HIV (PWH) experience increased morbidity and mortality. Cytomegalovirus (CMV) and Epstein--Barr virus (EBV) co-infections likely exacerbate inflammatory-related diseases. Objective: To determine if...
7.
Chaillon A, Gianella S, Little S, Caballero G, Barin F, Kosakovsky Pond S, et al.
Virus Evol . 2018 Sep; 2(1):vew012. PMID: 30186625
Transmission of multiple founder variants has been associated with faster HIV disease progression. Many studies have attempted to determine the number of founder variants, mainly by analysis of sequence diversity...
8.
Christensen-Quick A, Chaillon A, Yek C, Zanini F, Jordan P, Ignacio C, et al.
J Acquir Immune Defic Syndr . 2018 Aug; 79(3):e104-e107. PMID: 30085954
No abstract available.
9.
Smith M, Murrell B, Eren K, Ignacio C, Landais E, Weaver S, et al.
Virus Evol . 2018 Mar; 2(2):vew018. PMID: 29492273
The ability to study rapidly evolving viral populations has been constrained by the read length of next-generation sequencing approaches and the sampling depth of single-genome amplification methods. Here, we develop...
10.
Wagner G, Landais E, Caballero G, Phung P, Kosakovsky Pond S, Poignard P, et al.
J Virol . 2017 Jun; 91(17). PMID: 28615205
Understanding whether the neutralizing antibody (NAb) response impacts HIV-1 superinfection and how superinfection subsequently modulates the NAb response can help clarify correlates of protection from HIV exposures and better delineate...